In the case of the MAP3K8 (COT) gene, functional studies have shown that its increased expression (as a result of amplification) causes the reactivation of the MAPK pathway and resistance of melanoma cells to MAPK inhibitors [32]. Here, MAP3K8 is linked to melanoma.